🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Canada / NCT01635569
Recruiting Not applicable

Clinical Outcomes in Pediatric Obsessive-Compulsive Disorder

NCT01635569 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2012-10-01
Last updated
2023-05-12

Condition(s) studied

Obsessive-compulsive Disorder

Investigational drug(s) / intervention(s)

Group-based family cognitive-behavioural therapyWaitlist

Group-based family cognitive-behavioural therapy: Baseline and post-12 sessions

Waitlist: Baseline and post-12 sessions

Study summary

Obsessive-Compulsive Disorder (OCD) is a common neuropsychiatric illness beginning in childhood. Effective OCD treatments include cognitive-behaviour therapy (CBT) and medications but access to treatment is difficult and does not systematically include parents. The investigators will evaluate clinical and neural effects of Group-based Family CBT (GF-CBT), via a case-control study including: Group 1 - OCD cases receiving GF-CBT (N=90); Group 2 - OCD waitlist cases (N=90). Effects will be measured between baseline and completion of 12 GF-CBT sessions: comparing OCD severity and functioning changes between Groups 1 and 2.

Eligibility

Sex
ALL
Min age
5 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Male or female, aged 5-18 years old * Ability of subject and parent to provide informed assent/consent * English-speaking * Current DSM IV-TR Axis I diagnosis of childhood-onset OCD; Moderate to severe OCD (CY-BOCS≥16/40) Exclusion Criteria: * Current diagnosis of bipolar disorder, psychosis, mental retardation or pervasive developmental disorder (e.g., autism), and current or past substance dependence/abuse

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
BC Children's Hospital Research Institute Vancouver British Columbia Recruiting

More University of British Columbia trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT01635569 on ClinicalTrials.gov ↗ ← All trials in Canada